RxDoctor Payments Data

Yumiko Wong

Physician Assistant · Upland, CANPI 1730243551

Payments from drug & device makers

$2,615in general payments, 2019–2025

Across 109 payments — averaging $23.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$565
  • Pfizer$294
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$242
  • Lilly USA, LLC$197
  • Exact Sciences$194
  • Boehringer Ingelheim$169
  • plus $956 from 20 others

What the payments were for

  • Food & beverage$2,615100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,615 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban34$39,851
OzempicSemaglutide33$31,486
JanuviaSitagliptin Phosphate25$28,974
JardianceEmpagliflozin13$9,919
Breo ElliptaFluticasone/Vilanterol18$8,582
Humalog Kwikpen U-100Insulin Lispro12$2,769
Levothyroxine Sodium145$2,154
Atorvastatin Calcium148$1,511
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$1,290
Rosuvastatin Calcium82$1,206
Gabapentin75$1,065
Omeprazole65$1,000
Tamsulosin Hcl34$799
Fluticasone Propionate56$682
Losartan Potassium73$663

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$294$39,85134 claims
Novo NordiskOzempic$22$31,48633 claims
MerckJanuvia$82$28,97425 claims
Boehringer IngelheimJardiance$169$9,91913 claims
GSKBreo Ellipta$59$8,58218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Upland

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →